MedVenture is a venture capital fund focused on investing in MedTech projects with global potential, particularly in the research and development phase. The fund has an investment budget of PLN 40 million and supports projects that aim to innovate within the medical technology sector. While specific investment stages are not detailed, MedVenture's commitment to R&D suggests a focus on early to mid-stage investments.
Notable portfolio companies include NeuroPace, which has raised $30 million. MedVenture offers extensive smart money support, providing teams with critical know-how, relationships, and partnerships across various domains such as IT, international marketing, law, finance, research, development, and global scaling. The fund's team brings several hundred years of combined investment experience in the MedTech sector, ensuring robust guidance and strategic support for their portfolio companies.
MedVenture - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series C1 (100.0%)
Stage Mix
Series C 100%
Concentration shown as share of disclosed investments by stage.
